Jefferies Group LLC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 40 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q4 2020$52,147
-98.3%
48,000
-98.4%
0.00%
-100.0%
Q3 2020$3,065,000
-9.2%
2,935,000
-3.8%
0.03%
-15.0%
Q2 2020$3,377,000
-14.3%
3,051,000
-20.9%
0.04%
-9.1%
Q1 2020$3,942,000
+1278.3%
3,859,000
+1431.3%
0.04%
+2100.0%
Q4 2019$286,000
-87.9%
252,000
-87.8%
0.00%
-88.9%
Q3 2019$2,361,000
-55.1%
2,069,000
-53.3%
0.02%
-52.6%
Q2 2019$5,264,000
+79.9%
4,427,000
+104.7%
0.04%
+58.3%
Q1 2019$2,926,000
+85.9%
2,163,000
+45.7%
0.02%
+140.0%
Q3 2018$1,574,000
-46.5%
1,485,000
-50.5%
0.01%
-37.5%
Q2 2018$2,943,000
+506.8%
3,003,000
+512.9%
0.02%
+433.3%
Q1 2018$485,000
-76.4%
490,000
-75.6%
0.00%
-72.7%
Q4 2016$2,051,000
+196.4%
2,012,000
+106.4%
0.01%
+266.7%
Q2 2016$692,000
-25.1%
975,000
+18.8%
0.00%
-40.0%
Q4 2015$924,000821,0000.01%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q3 2016
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 74,881,000$76,559,0001.97%
III Capital Management 15,000,000$15,227,0001.82%
TFG Asset Management GP Ltd 14,055,000$14,321,0001.02%
MACKAY SHIELDS LLC 28,304,000$28,739,0000.21%
RWC Asset Management LLP 6,500,000$6,604,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 7,187,000$7,281,0000.17%
CQS (US), LLC 4,000,000$4,092,0000.13%
FARALLON CAPITAL MANAGEMENT LLC 24,435,000$24,797,0000.12%
D. E. Shaw & Co., Inc. 59,728,000$60,845,0000.06%
BNP Paribas Asset Management Holding S.A. 7,000,000$7,133,0000.03%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders